These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35150156)

  • 1. Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo-controlled trial.
    Russell N; Allebone J; Dandash O; Hoermann R; Cheung AS; Zajac JD; Handelsman DJ; Kanaan RA; Grossmann M
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):622-633. PubMed ID: 35150156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial.
    Russell N; Hoermann R; Cheung AS; Zajac JD; Grossmann M
    Eur J Endocrinol; 2022 Nov; 187(5):617-627. PubMed ID: 36806623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Russell N; Hoermann R; Cheung AS; Zajac JD; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2021 Nov; 186(1):9-23. PubMed ID: 34678758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of long-term androgen deprivation therapy on cognitive function and socioeconomic decision making in prostate cancer patients.
    Holtfrerich SKC; Knipper S; Purwins J; Castens J; Beyer B; Schlomm T; Diekhof EK
    Psychooncology; 2020 Aug; 29(8):1338-1346. PubMed ID: 32539186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog.
    Matousek RH; Sherwin BB
    Psychoneuroendocrinology; 2010 Feb; 35(2):215-25. PubMed ID: 19615826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial.
    Russell N; Hoermann R; Cheung AS; Ching M; Zajac JD; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2018 May; 178(5):565-576. PubMed ID: 29549104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial.
    Russell N; Ghasem-Zadeh A; Hoermann R; Cheung AS; Zajac JD; Shore-Lorenti C; Ebeling PR; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2022 Aug; 187(2):241-256. PubMed ID: 35666800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multicomponent resistance-based exercise program with protein, vitamin D and calcium supplementation on cognition in men with prostate cancer treated with ADT: secondary analysis of a 12-month randomised controlled trial.
    Mundell NL; Owen PJ; Dalla Via J; Macpherson H; Daly RM; Livingston PM; Rantalainen T; Foulkes S; Millar J; Murphy DG; Fraser SF
    BMJ Open; 2022 Jun; 12(6):e060189. PubMed ID: 35750461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testosterone loss and estradiol administration modify memory in men.
    Beer TM; Bland LB; Bussiere JR; Neiss MB; Wersinger EM; Garzotto M; Ryan CW; Janowsky JS
    J Urol; 2006 Jan; 175(1):130-5. PubMed ID: 16406889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of walking exercise in promoting cognitive-psychosocial functions in men with prostate cancer receiving androgen deprivation therapy.
    Lee CE; Kilgour A; Lau YK
    BMC Cancer; 2012 Jul; 12():324. PubMed ID: 22846379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Androgen Deprivation Therapy on Pain Perception, Quality of Life, and Depression in Men With Prostate Cancer.
    Gagliano-Jucá T; Travison TG; Nguyen PL; Kantoff PW; Taplin ME; Kibel AS; Manley R; Hally K; Bearup R; Beleva YM; Huang G; Edwards RR; Basaria S
    J Pain Symptom Manage; 2018 Feb; 55(2):307-317.e1. PubMed ID: 28941963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermittent Androgen Deprivation Therapy for Biochemical Recurrence following Radical Local Therapy.
    Klotz L; Loblaw A; Siemens R; Ouellette P; Kapoor A; Kebabdjian M; Zhang L; Saad F;
    J Urol; 2018 Aug; 200(2):335-343. PubMed ID: 29534997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of androgen deprivation therapy on telomere length.
    Cheung AS; Yeap BB; Hoermann R; Hui J; Beilby JP; Grossmann M
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):381-385. PubMed ID: 28543303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and cognition during androgen deprivation in men with prostate carcinoma.
    Salminen EK; Portin RI; Koskinen AI; Helenius HY; Nurmi MJ
    Cancer; 2005 Apr; 103(7):1381-7. PubMed ID: 15717315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depressive symptoms are found to be potential adverse effects of androgen deprivation therapy in older prostate cancer patients: A 15-month prospective, observational study.
    Zhang Z; Yang L; Xie D; Shi H; Li G; Yu D
    Psychooncology; 2017 Dec; 26(12):2238-2244. PubMed ID: 28474429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men.
    Almeida OP; Waterreus A; Spry N; Flicker L; Martins RN
    Psychoneuroendocrinology; 2004 Sep; 29(8):1071-81. PubMed ID: 15219659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating inflammatory cytokine expression in men with prostate cancer undergoing androgen deprivation therapy.
    Maggio M; Blackford A; Taub D; Carducci M; Ble A; Metter EJ; Braga-Basaria M; Dobs A; Basaria S
    J Androl; 2006; 27(6):725-8. PubMed ID: 16775253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone Treatment and Cognitive Function in Older Men With Low Testosterone and Age-Associated Memory Impairment.
    Resnick SM; Matsumoto AM; Stephens-Shields AJ; Ellenberg SS; Gill TM; Shumaker SA; Pleasants DD; Barrett-Connor E; Bhasin S; Cauley JA; Cella D; Crandall JP; Cunningham GR; Ensrud KE; Farrar JT; Lewis CE; Molitch ME; Pahor M; Swerdloff RS; Cifelli D; Anton S; Basaria S; Diem SJ; Wang C; Hou X; Snyder PJ
    JAMA; 2017 Feb; 317(7):717-727. PubMed ID: 28241356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.